By: T. Vermassen PhD, A. Decruyenaere MD, D. De Maeseneer MD, S. Rottey MD, PhD
The 2024 annual ASCO meeting offered remarkable presentations about the lastest trial updates in renal cell, bladder, testicular and prostate cancer. This article will give an overview of the key highlights in genitourinary cancers presented at ASCO 2024.
(Belg J Med Oncol 2024;18(5):206–10)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
